Mirati Therapeutics Common
|
17.2 |
$996M |
|
4.5M |
219.64 |
Horizon Therapeutics Common
|
11.3 |
$658M |
|
9.0M |
73.15 |
United Therapeutics Corp Common
(UTHR)
|
7.5 |
$433M |
|
2.9M |
151.79 |
Iovance Biotherapeutics Common
(IOVA)
|
6.0 |
$348M |
|
7.5M |
46.40 |
Arena Pharmaceuticals Common
|
5.5 |
$322M |
|
4.2M |
76.83 |
Ascendis Pharma Sponsored ADR
(ASND)
|
5.2 |
$300M |
|
1.8M |
166.78 |
Sarepta Therapeutics Common
(SRPT)
|
5.1 |
$298M |
|
1.8M |
170.49 |
Argenx Se Sponsored ADR
(ARGX)
|
4.6 |
$265M |
|
903k |
294.09 |
Amicus Therapeutics Common
(FOLD)
|
3.6 |
$208M |
|
9.0M |
23.09 |
Acceleron Pharma Common
|
3.4 |
$198M |
|
1.6M |
127.94 |
Mersana Therapeutics Common
(MRSN)
|
3.1 |
$181M |
|
6.8M |
26.61 |
Biomarin Pharmaceutical Common
(BMRN)
|
2.5 |
$145M |
|
1.7M |
87.69 |
Madrigal Pharmaceuticals Common
(MDGL)
|
2.3 |
$136M |
|
1.2M |
111.17 |
Kura Oncology Common
(KURA)
|
2.2 |
$131M |
|
4.0M |
32.66 |
Pmv Pharmaceuticals Common
(PMVP)
|
2.2 |
$131M |
|
2.4M |
55.54 |
Acadia Pharmaceuticals Common
(ACAD)
|
1.8 |
$104M |
|
2.0M |
53.46 |
Adverum Biotechnologies Common
|
1.5 |
$87M |
|
8.0M |
10.84 |
Trillium Therapeutics Common
|
1.5 |
$85M |
|
5.8M |
14.71 |
Constellation Pharmaceuticals Common
|
1.5 |
$85M |
|
3.0M |
28.80 |
Deciphera Pharmaceuticals Common
|
1.3 |
$74M |
|
1.3M |
57.07 |
Praxis Precision Medicines Common
|
1.2 |
$69M |
|
1.5M |
44.46 |
Cymabay Therapeutics Common
|
1.0 |
$59M |
|
10M |
5.74 |
Iveric Bio Common
|
0.9 |
$50M |
|
7.3M |
6.91 |
Travere Therapeutics Common
(TVTX)
|
0.8 |
$49M |
|
1.8M |
27.26 |
Relmada Therapeutics Common
(RLMD)
|
0.8 |
$49M |
|
1.5M |
32.07 |
Xenon Pharmaceuticals Common
(XENE)
|
0.7 |
$43M |
|
2.8M |
15.38 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.7 |
$39M |
|
3.2M |
12.20 |
Olema Pharmaceuticals Common
(OLMA)
|
0.6 |
$36M |
|
877k |
40.65 |
Amarin Corp Sponsored ADR
(AMRN)
|
0.5 |
$29M |
|
6.0M |
4.89 |
Avadel Pharmaceuticals Sponsored ADR
|
0.5 |
$29M |
|
4.4M |
6.68 |
Relay Therapeutics Common
(RLAY)
|
0.4 |
$21M |
|
500k |
41.56 |
Black Diamond Therapeutics Common
(BDTX)
|
0.4 |
$21M |
|
640k |
32.05 |
Adaptimmune Therapeutics Sponsored ADR
(ADAP)
|
0.3 |
$19M |
|
3.6M |
5.39 |
Iteos Therapeutics Common
(ITOS)
|
0.3 |
$16M |
|
460k |
33.82 |
Therapeutics Acquisition Corp Common
|
0.2 |
$14M |
|
1.0M |
13.95 |
Avidity Biosciences Common
(RNA)
|
0.2 |
$14M |
|
545k |
25.52 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$12M |
|
1.7M |
7.45 |
Genocea Biosciences Common
(GNCAQ)
|
0.2 |
$12M |
|
5.1M |
2.42 |
Mannkind Corp Common
(MNKD)
|
0.2 |
$11M |
|
3.5M |
3.13 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.2 |
$10M |
|
450k |
22.24 |
Bctg Acquisition Corp Common
|
0.2 |
$9.2M |
|
800k |
11.44 |
Cue Biopharma Common
(CUE)
|
0.1 |
$5.7M |
|
453k |
12.51 |
Athenex Common
|
0.1 |
$4.1M |
|
373k |
11.06 |
Nektar Therapeutics Common Call Option
(NKTR)
|
0.0 |
$26k |
|
100k |
0.26 |